EE+ POEM Archive
In older adults with cardiovascular disease, SGLT2 inhibitors significantly decrease all-cause mortality, cardiovascular events, and heart failure events
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "In Older Adults With Cardiovascular Disease, SGLT2 Inhibitors Significantly Decrease All-cause Mortality, Cardiovascular Events, and Heart Failure Events." EE+ POEM Archive, John Wiley & Sons, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377590/all/In_older_adults_with_cardiovascular_disease__SGLT2_inhibitors_significantly_decrease_all_cause_mortality__cardiovascular_events__and_heart_failure_events.
In older adults with cardiovascular disease, SGLT2 inhibitors significantly decrease all-cause mortality, cardiovascular events, and heart failure events. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2026. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377590/all/In_older_adults_with_cardiovascular_disease__SGLT2_inhibitors_significantly_decrease_all_cause_mortality__cardiovascular_events__and_heart_failure_events. Accessed March 16, 2026.
In older adults with cardiovascular disease, SGLT2 inhibitors significantly decrease all-cause mortality, cardiovascular events, and heart failure events. (2026). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377590/all/In_older_adults_with_cardiovascular_disease__SGLT2_inhibitors_significantly_decrease_all_cause_mortality__cardiovascular_events__and_heart_failure_events
In Older Adults With Cardiovascular Disease, SGLT2 Inhibitors Significantly Decrease All-cause Mortality, Cardiovascular Events, and Heart Failure Events [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2026. [cited 2026 March 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377590/all/In_older_adults_with_cardiovascular_disease__SGLT2_inhibitors_significantly_decrease_all_cause_mortality__cardiovascular_events__and_heart_failure_events.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - In older adults with cardiovascular disease, SGLT2 inhibitors significantly decrease all-cause mortality, cardiovascular events, and heart failure events
ID - 3377590
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377590/all/In_older_adults_with_cardiovascular_disease__SGLT2_inhibitors_significantly_decrease_all_cause_mortality__cardiovascular_events__and_heart_failure_events
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
